img

Global Etoricoxib Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Etoricoxib Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Etoricoxib is a selective COX-2 inhibitor used to relieve dental pain after moderate surgery as a short-term treatment and inflammation and pain symptoms of various forms of arthritis.
Etoricoxib report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Etoricoxib market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Etoricoxib industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Etoricoxib key manufacturers include Morepen Laboratories, Merck & Co, Frosst Iberica SA, Metrochem API, Atom Pharma, Hema Pharmaceuticals, Beijing Tide Pharmaceutical, Qilu Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. Morepen Laboratories, Merck & Co, Frosst Iberica SA are top 3 players and held % sales share in total in 2022.
Etoricoxib can be divided into 30 mg, 60 mg, 90 mg and 120 mg, etc. 30 mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Etoricoxib is widely used in various fields, such as Hospital, Pharmacy and Others,, etc. Hospital provides greatest supports to the Etoricoxib industry development. In 2022, global % sales of Etoricoxib went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Etoricoxib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Morepen Laboratories
Merck & Co
Frosst Iberica SA
Metrochem API
Atom Pharma
Hema Pharmaceuticals
Beijing Tide Pharmaceutical
Qilu Pharmaceutical
Shanghai Shyndec Pharmaceutical
Easton Biopharmaceuticals
Segment by Type
30 mg
60 mg
90 mg
120 mg

Segment by Application


Hospital
Pharmacy
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Etoricoxib market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Etoricoxib, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Etoricoxib industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Etoricoxib in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Etoricoxib introduction, etc. Etoricoxib Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Etoricoxib market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Etoricoxib Market Overview
1.1 Etoricoxib Product Overview
1.2 Etoricoxib Market Segment by Type
1.2.1 30 mg
1.2.2 60 mg
1.2.3 90 mg
1.2.4 120 mg
1.3 Global Etoricoxib Market Size by Type
1.3.1 Global Etoricoxib Market Size Overview by Type (2024-2034)
1.3.2 Global Etoricoxib Historic Market Size Review by Type (2024-2024)
1.3.3 Global Etoricoxib Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Etoricoxib Sales Breakdown by Type (2024-2024)
1.4.2 Europe Etoricoxib Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Etoricoxib Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Etoricoxib Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Etoricoxib Sales Breakdown by Type (2024-2024)
2 Global Etoricoxib Market Competition by Company
2.1 Global Top Players by Etoricoxib Sales (2024-2024)
2.2 Global Top Players by Etoricoxib Revenue (2024-2024)
2.3 Global Top Players by Etoricoxib Price (2024-2024)
2.4 Global Top Manufacturers Etoricoxib Manufacturing Base Distribution, Sales Area, Product Type
2.5 Etoricoxib Market Competitive Situation and Trends
2.5.1 Etoricoxib Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Etoricoxib Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Etoricoxib as of 2022)
2.7 Date of Key Manufacturers Enter into Etoricoxib Market
2.8 Key Manufacturers Etoricoxib Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Etoricoxib Status and Outlook by Region
3.1 Global Etoricoxib Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Etoricoxib Historic Market Size by Region
3.2.1 Global Etoricoxib Sales in Volume by Region (2024-2024)
3.2.2 Global Etoricoxib Sales in Value by Region (2024-2024)
3.2.3 Global Etoricoxib Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Etoricoxib Forecasted Market Size by Region
3.3.1 Global Etoricoxib Sales in Volume by Region (2024-2034)
3.3.2 Global Etoricoxib Sales in Value by Region (2024-2034)
3.3.3 Global Etoricoxib Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Etoricoxib by Application
4.1 Etoricoxib Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Others
4.2 Global Etoricoxib Market Size by Application
4.2.1 Global Etoricoxib Market Size Overview by Application (2024-2034)
4.2.2 Global Etoricoxib Historic Market Size Review by Application (2024-2024)
4.2.3 Global Etoricoxib Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Etoricoxib Sales Breakdown by Application (2024-2024)
4.3.2 Europe Etoricoxib Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Etoricoxib Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Etoricoxib Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Etoricoxib Sales Breakdown by Application (2024-2024)
5 North America Etoricoxib by Country
5.1 North America Etoricoxib Historic Market Size by Country
5.1.1 North America Etoricoxib Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Etoricoxib Sales in Volume by Country (2024-2024)
5.1.3 North America Etoricoxib Sales in Value by Country (2024-2024)
5.2 North America Etoricoxib Forecasted Market Size by Country
5.2.1 North America Etoricoxib Sales in Volume by Country (2024-2034)
5.2.2 North America Etoricoxib Sales in Value by Country (2024-2034)
6 Europe Etoricoxib by Country
6.1 Europe Etoricoxib Historic Market Size by Country
6.1.1 Europe Etoricoxib Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Etoricoxib Sales in Volume by Country (2024-2024)
6.1.3 Europe Etoricoxib Sales in Value by Country (2024-2024)
6.2 Europe Etoricoxib Forecasted Market Size by Country
6.2.1 Europe Etoricoxib Sales in Volume by Country (2024-2034)
6.2.2 Europe Etoricoxib Sales in Value by Country (2024-2034)
7 Asia-Pacific Etoricoxib by Region
7.1 Asia-Pacific Etoricoxib Historic Market Size by Region
7.1.1 Asia-Pacific Etoricoxib Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Etoricoxib Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Etoricoxib Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Etoricoxib Forecasted Market Size by Region
7.2.1 Asia-Pacific Etoricoxib Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Etoricoxib Sales in Value by Region (2024-2034)
8 Latin America Etoricoxib by Country
8.1 Latin America Etoricoxib Historic Market Size by Country
8.1.1 Latin America Etoricoxib Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Etoricoxib Sales in Volume by Country (2024-2024)
8.1.3 Latin America Etoricoxib Sales in Value by Country (2024-2024)
8.2 Latin America Etoricoxib Forecasted Market Size by Country
8.2.1 Latin America Etoricoxib Sales in Volume by Country (2024-2034)
8.2.2 Latin America Etoricoxib Sales in Value by Country (2024-2034)
9 Middle East and Africa Etoricoxib by Country
9.1 Middle East and Africa Etoricoxib Historic Market Size by Country
9.1.1 Middle East and Africa Etoricoxib Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Etoricoxib Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Etoricoxib Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Etoricoxib Forecasted Market Size by Country
9.2.1 Middle East and Africa Etoricoxib Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Etoricoxib Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Morepen Laboratories
10.1.1 Morepen Laboratories Company Information
10.1.2 Morepen Laboratories Introduction and Business Overview
10.1.3 Morepen Laboratories Etoricoxib Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Morepen Laboratories Etoricoxib Products Offered
10.1.5 Morepen Laboratories Recent Development
10.2 Merck & Co
10.2.1 Merck & Co Company Information
10.2.2 Merck & Co Introduction and Business Overview
10.2.3 Merck & Co Etoricoxib Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck & Co Etoricoxib Products Offered
10.2.5 Merck & Co Recent Development
10.3 Frosst Iberica SA
10.3.1 Frosst Iberica SA Company Information
10.3.2 Frosst Iberica SA Introduction and Business Overview
10.3.3 Frosst Iberica SA Etoricoxib Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Frosst Iberica SA Etoricoxib Products Offered
10.3.5 Frosst Iberica SA Recent Development
10.4 Metrochem API
10.4.1 Metrochem API Company Information
10.4.2 Metrochem API Introduction and Business Overview
10.4.3 Metrochem API Etoricoxib Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Metrochem API Etoricoxib Products Offered
10.4.5 Metrochem API Recent Development
10.5 Atom Pharma
10.5.1 Atom Pharma Company Information
10.5.2 Atom Pharma Introduction and Business Overview
10.5.3 Atom Pharma Etoricoxib Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Atom Pharma Etoricoxib Products Offered
10.5.5 Atom Pharma Recent Development
10.6 Hema Pharmaceuticals
10.6.1 Hema Pharmaceuticals Company Information
10.6.2 Hema Pharmaceuticals Introduction and Business Overview
10.6.3 Hema Pharmaceuticals Etoricoxib Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Hema Pharmaceuticals Etoricoxib Products Offered
10.6.5 Hema Pharmaceuticals Recent Development
10.7 Beijing Tide Pharmaceutical
10.7.1 Beijing Tide Pharmaceutical Company Information
10.7.2 Beijing Tide Pharmaceutical Introduction and Business Overview
10.7.3 Beijing Tide Pharmaceutical Etoricoxib Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Beijing Tide Pharmaceutical Etoricoxib Products Offered
10.7.5 Beijing Tide Pharmaceutical Recent Development
10.8 Qilu Pharmaceutical
10.8.1 Qilu Pharmaceutical Company Information
10.8.2 Qilu Pharmaceutical Introduction and Business Overview
10.8.3 Qilu Pharmaceutical Etoricoxib Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Qilu Pharmaceutical Etoricoxib Products Offered
10.8.5 Qilu Pharmaceutical Recent Development
10.9 Shanghai Shyndec Pharmaceutical
10.9.1 Shanghai Shyndec Pharmaceutical Company Information
10.9.2 Shanghai Shyndec Pharmaceutical Introduction and Business Overview
10.9.3 Shanghai Shyndec Pharmaceutical Etoricoxib Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Shanghai Shyndec Pharmaceutical Etoricoxib Products Offered
10.9.5 Shanghai Shyndec Pharmaceutical Recent Development
10.10 Easton Biopharmaceuticals
10.10.1 Easton Biopharmaceuticals Company Information
10.10.2 Easton Biopharmaceuticals Introduction and Business Overview
10.10.3 Easton Biopharmaceuticals Etoricoxib Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Easton Biopharmaceuticals Etoricoxib Products Offered
10.10.5 Easton Biopharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Etoricoxib Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Etoricoxib Industrial Chain Analysis
11.4 Etoricoxib Market Dynamics
11.4.1 Etoricoxib Industry Trends
11.4.2 Etoricoxib Market Drivers
11.4.3 Etoricoxib Market Challenges
11.4.4 Etoricoxib Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Etoricoxib Distributors
12.3 Etoricoxib Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 30 mg
Table 2. Major Company of 60 mg
Table 3. Major Company of 90 mg
Table 4. Major Company of 120 mg
Table 5. Global Etoricoxib Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Etoricoxib Sales by Type (2024-2024) & (K Units)
Table 7. Global Etoricoxib Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Etoricoxib Sales by Type (2024-2024) & (US& Million)
Table 9. Global Etoricoxib Market Share in Value by Type (2024-2024)
Table 10. Global Etoricoxib Price by Type (2024-2024) & (US$/Unit)
Table 11. Global Etoricoxib Sales by Type (2024-2034) & (K Units)
Table 12. Global Etoricoxib Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Etoricoxib Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Etoricoxib Sales Market Share in Value by Type (2024-2034)
Table 15. Global Etoricoxib Price by Type (2024-2034) & (US$/Unit)
Table 16. North America Etoricoxib Sales by Type (2024-2024) & (K Units)
Table 17. North America Etoricoxib Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Etoricoxib Sales (K Units) by Type (2024-2024)
Table 19. Europe Etoricoxib Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Etoricoxib Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Etoricoxib Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Etoricoxib Sales (K Units) by Type (2024-2024)
Table 23. Latin America Etoricoxib Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Etoricoxib Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Etoricoxib Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Etoricoxib Sales by Company (2024-2024) & (K Units)
Table 27. Global Etoricoxib Sales Share by Company (2024-2024)
Table 28. Global Etoricoxib Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Etoricoxib Revenue Share by Company (2024-2024)
Table 30. Global Market Etoricoxib Price by Company (2024-2024) & (US$/Unit)
Table 31. Global Etoricoxib Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Etoricoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Etoricoxib as of 2022)
Table 34. Date of Key Manufacturers Enter into Etoricoxib Market
Table 35. Key Manufacturers Etoricoxib Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Etoricoxib Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Etoricoxib Sales by Region (2024-2024) & (K Units)
Table 39. Global Etoricoxib Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Etoricoxib Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Etoricoxib Sales Market Share in Value by Region (2024-2024)
Table 42. Global Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 43. Global Etoricoxib Sales by Region (2024-2034) & (K Units)
Table 44. Global Etoricoxib Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Etoricoxib Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Etoricoxib Sales Market Share in Value by Region (2024-2034)
Table 47. Global Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 48. Global Etoricoxib Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Etoricoxib Sales by Application (2024-2024) & (K Units)
Table 50. Global Etoricoxib Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Etoricoxib Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Etoricoxib Sales Market Share in Value by Application (2024-2024)
Table 53. Global Etoricoxib Price by Application (2024-2024) & (US$/Unit)
Table 54. Global Etoricoxib Sales by Application (2024-2034) & (K Units)
Table 55. Global Etoricoxib Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Etoricoxib Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Etoricoxib Sales Market Share in Value by Application (2024-2034)
Table 58. Global Etoricoxib Price by Application (2024-2034) & (US$/Unit)
Table 59. North America Etoricoxib Sales by Application (2024-2024) (K Units)
Table 60. North America Etoricoxib Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Etoricoxib Sales by Application (2024-2024) (K Units)
Table 62. Europe Etoricoxib Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Etoricoxib Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Etoricoxib Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Etoricoxib Sales by Application (2024-2024) (K Units)
Table 66. Latin America Etoricoxib Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Etoricoxib Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Etoricoxib Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Etoricoxib Sales by Country (2024-2024) & (K Units)
Table 70. North America Etoricoxib Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Etoricoxib Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Etoricoxib Sales Market Share in Value by Country (2024-2024)
Table 73. North America Etoricoxib Sales by Country (2024-2034) & (K Units)
Table 74. North America Etoricoxib Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Etoricoxib Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Etoricoxib Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Etoricoxib Sales by Country (2024-2024) & (K Units)
Table 78. Europe Etoricoxib Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Etoricoxib Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Etoricoxib Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Etoricoxib Sales by Country (2024-2034) & (K Units)
Table 82. Europe Etoricoxib Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Etoricoxib Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Etoricoxib Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Etoricoxib Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Etoricoxib Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Etoricoxib Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Etoricoxib Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Etoricoxib Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Etoricoxib Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Etoricoxib Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Etoricoxib Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Etoricoxib Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Etoricoxib Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Etoricoxib Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Etoricoxib Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Etoricoxib Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Etoricoxib Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Etoricoxib Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Etoricoxib Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Etoricoxib Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Etoricoxib Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Etoricoxib Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Etoricoxib Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Etoricoxib Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Etoricoxib Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Etoricoxib Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Etoricoxib Sales Market Share in Value by Country (2024-2034)
Table 109. Morepen Laboratories Company Information
Table 110. Morepen Laboratories Introduction and Business Overview
Table 111. Morepen Laboratories Etoricoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 112. Morepen Laboratories Etoricoxib Product
Table 113. Morepen Laboratories Recent Development
Table 114. Merck & Co Company Information
Table 115. Merck & Co Introduction and Business Overview
Table 116. Merck & Co Etoricoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 117. Merck & Co Etoricoxib Product
Table 118. Merck & Co Recent Development
Table 119. Frosst Iberica SA Company Information
Table 120. Frosst Iberica SA Introduction and Business Overview
Table 121. Frosst Iberica SA Etoricoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 122. Frosst Iberica SA Etoricoxib Product
Table 123. Frosst Iberica SA Recent Development
Table 124. Metrochem API Company Information
Table 125. Metrochem API Introduction and Business Overview
Table 126. Metrochem API Etoricoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 127. Metrochem API Etoricoxib Product
Table 128. Metrochem API Recent Development
Table 129. Atom Pharma Company Information
Table 130. Atom Pharma Introduction and Business Overview
Table 131. Atom Pharma Etoricoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 132. Atom Pharma Etoricoxib Product
Table 133. Atom Pharma Recent Development
Table 134. Hema Pharmaceuticals Company Information
Table 135. Hema Pharmaceuticals Introduction and Business Overview
Table 136. Hema Pharmaceuticals Etoricoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 137. Hema Pharmaceuticals Etoricoxib Product
Table 138. Hema Pharmaceuticals Recent Development
Table 139. Beijing Tide Pharmaceutical Company Information
Table 140. Beijing Tide Pharmaceutical Introduction and Business Overview
Table 141. Beijing Tide Pharmaceutical Etoricoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 142. Beijing Tide Pharmaceutical Etoricoxib Product
Table 143. Beijing Tide Pharmaceutical Recent Development
Table 144. Qilu Pharmaceutical Company Information
Table 145. Qilu Pharmaceutical Introduction and Business Overview
Table 146. Qilu Pharmaceutical Etoricoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 147. Qilu Pharmaceutical Etoricoxib Product
Table 148. Qilu Pharmaceutical Recent Development
Table 149. Shanghai Shyndec Pharmaceutical Company Information
Table 150. Shanghai Shyndec Pharmaceutical Introduction and Business Overview
Table 151. Shanghai Shyndec Pharmaceutical Etoricoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 152. Shanghai Shyndec Pharmaceutical Etoricoxib Product
Table 153. Shanghai Shyndec Pharmaceutical Recent Development
Table 154. Easton Biopharmaceuticals Company Information
Table 155. Easton Biopharmaceuticals Introduction and Business Overview
Table 156. Easton Biopharmaceuticals Etoricoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 157. Easton Biopharmaceuticals Etoricoxib Product
Table 158. Easton Biopharmaceuticals Recent Development
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Etoricoxib Market Trends
Table 162. Etoricoxib Market Drivers
Table 163. Etoricoxib Market Challenges
Table 164. Etoricoxib Market Restraints
Table 165. Etoricoxib Distributors List
Table 166. Etoricoxib Downstream Customers
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Etoricoxib Product Picture
Figure 2. Global Etoricoxib Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Etoricoxib Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Etoricoxib Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of 30 mg
Figure 6. Global 30 mg Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of 60 mg
Figure 8. Global 60 mg Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of 90 mg
Figure 10. Global 90 mg Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of 120 mg
Figure 12. Global 120 mg Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Etoricoxib Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Etoricoxib Sales Market Share by Type in 2022 & 2034
Figure 15. North America Etoricoxib Sales Market Share in Volume by Type in 2022
Figure 16. North America Etoricoxib Sales Market Share in Value by Type in 2022
Figure 17. Europe Etoricoxib Sales Market Share in Volume by Type in 2022
Figure 18. Europe Etoricoxib Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Etoricoxib Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Etoricoxib Sales Market Share in Value by Type in 2022
Figure 21. Latin America Etoricoxib Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Etoricoxib Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Etoricoxib Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Etoricoxib Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Etoricoxib Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Etoricoxib Revenue in 2022
Figure 27. Etoricoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Pharmacy
Figure 31. Global Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Etoricoxib Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Etoricoxib Sales Market Share by Application in 2022 & 2034
Figure 36. North America Etoricoxib Sales Market Share in Volume by Application in 2022
Figure 37. North America Etoricoxib Sales Market Share in Value by Application in 2022
Figure 38. Europe Etoricoxib Sales Market Share in Volume by Application in 2022
Figure 39. Europe Etoricoxib Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Etoricoxib Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Etoricoxib Sales Market Share in Value by Application in 2022
Figure 42. Latin America Etoricoxib Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Etoricoxib Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Etoricoxib Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Etoricoxib Manufacturing Cost Structure
Figure 47. Etoricoxib Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed